Brandon de White

Brandon de White serves as a Contract Specialist responsible for managing the full lifecycle of federal acquisitions, from requirements definition through contract award and administration. He plays a critical role in ensuring compliance with FAR regulations while advancing mission-critical scientific research initiatives. His procurement portfolio is heavily focused on research and development services, particularly in the life sciences and biotechnology domains. He works closely with technical stakeholders to translate complex scientific needs into solicitation requirements that attract qualified vendors while maintaining rigorous oversight and accountability throughout contract performance. While no specific contractor relationships are currently identifiable in the data, de White consistently engages with a broad spectrum of vendors, including both large research institutions and specialized small businesses capable of delivering advanced scientific and technical services. His contracting patterns reflect a preference for competitive, open-market solicitations, with a structured approach to evaluating technical merit, past performance, and compliance with federal procurement standards. He fosters collaborative relationships with industry partners to ensure innovation is aligned with agency objectives, even in the absence of formal long-term contract vehicles. De White’s set-aside preferences demonstrate a strong but measured commitment to small business participation, with 8.3% of his awards designated as Total Small Business Set-Asides under FAR 19.5. While the majority of his acquisitions remain open to all competitors, his consistent use of small business set-asides signals a deliberate effort to expand opportunities for qualified small firms without compromising competition or mission outcomes. He does not currently utilize 8(a), HUBZone, or SDVOSB-specific set-asides, indicating a focus on broad-based small business inclusion rather than targeted socioeconomic programs. His primary procurement focus lies in NAICS 541714 (Biotechnology R&D) and 541712 (Physical, Engineering, and Life Sciences R&D), reflecting deep expertise in procuring laboratory services, clinical research support, analytical instrumentation, and proprietary scientific methodologies. He specializes in acquisitions involving experimental design, data analysis, and translational research, making him a key liaison between federal science missions and the innovation ecosystem.